Sort
40,608 grants matching “prostate cancer”
PHASE III TRIAL OF SELENIUM FOR PROSTATE CANCER PREVENT
$874,621University Of Arizona · R01 · FY2000 · CA
Emory, Harvard & Univ. of Washington Prostate Cancer Biomarker Center
$874,523Martin G Sanda · Emory University · U01 · FY2017 · CA
Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent
$874,253Eric Scott Bensen · Vergent Bioscience, Inc. · R44 · FY2023 · CA
Elucidation of cancer pathways and druggable targets using mouse models.
$873,915Cory Abate-Shen · Columbia University Health Sciences · U01 · FY2011 · CA
Transcription Dynamics in Single Cells
$873,542Daniel Larson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
$873,293Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Assessing the impact of app-delivered lighting interventions on fatigue in three populations of cancer patients
$873,205Olivia Walch · Arcascope, Inc · R44 · FY2020 · CA
Molecular prediction of myeloma in African Americans
$872,957Irene M. Ghobrial · Dana-Farber Cancer Inst · U01 · FY2025 · CA
NONINVASIVE DETECTION OF AR-FL/AR-V7 AS A PREDICTIVE BIOMARKER FOR THERAPEUTIC RESISTANCE IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
$872,746University Of Washington · · FY2015 · Department of the Army
Radiation-induced translational control of gene expression
$872,517Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
SBIR Phase II: Food Antioxidants (AOs) With or Without Estrogenic Activity (EA)
$872,425Cathy Yang · Certichem, Inc · · FY2010 · TIP
Post-translational modifications of Hsp90
$872,254Leonard Neckers · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
HSP90 and HSP70 Chaperone Proteins and Interactors in Cellular Signal Transduction
$872,254Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
$871,799Elizabeth L Travis · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
DETECTION AND CHARACTERIZATION OF TREATMENT EMERGENT NEUROENDOCRINE PROSTATE CANCER USING HYPERPOLARIZED 13C MAGNETIC RESONANCE
$871,748Regents Of The University Of California, San Francisco, The · · FY2017 · Department of the Army
Center for Interventional Oncology
$871,672Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2020 · CA
DATA SCIENCE TO IMPROVE TREATMENT PLANNING FOR ADVANCED PROSTATE CANCER PATIENTS TREATED WITH RADIOTHERAPY
$871,390H. Lee Moffitt Cancer Center And Research Institute Lifetime Cancer Screening Center, Inc. · · FY2022 · Defense Health Agency
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$871,023William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
$870,850Samuel E. Adunyah · Meharry Medical College · U54 · FY2015 · CA
Developmental Funds
$870,774Michael A Caligiuri · Ohio State University · P30 · FY2007 · CA
One-click Automated 3D Treatment Planning for Radiopharmaceutical Therapy
$870,217Paul Wickre · Voximetry, Inc. · R44 · FY2021 · CA
Signal Transduction Events and the Regulation of Cell Growth
$870,159Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2016 · CA
Mouse Models for Human Prostate Cancer
$869,845Charles L Sawyers · Sloan-Kettering Inst Can Research · U01 · FY2007 · CA
METABOLOMICS OF MENTHOL CIGARETTE SMOKING AND RISK FOR AGGRESSIVE PROSTATE CANCER AMONG AFRICAN AMERICAN MEN
$869,759University Of Arkansas For Medical Sciences · · FY2021 · Defense Health Agency
Mouse Models for Human Prostate Cancer
$869,732Charles L Sawyers · University Of California Los Angeles · U01 · FY2006 · CA